Gliclazide and Metformin Tablets are a combination medicine used to manage type 2 diabetes mellitus by controlling blood sugar levels through complementary mechanisms.

Here are the key details:

• Composition: Each tablet contains:

  • Gliclazide – a sulfonylurea that stimulates insulin release from the pancreas.

  • Metformin – a biguanide that reduces glucose production in the liver and improves insulin sensitivity.

• Dosage Form: Oral tablets, usually taken once or twice daily with meals, as prescribed by a doctor.

• Mode of Action:

  • Gliclazide: Increases insulin secretion to lower blood glucose.

  • Metformin: Decreases hepatic glucose output and improves the body’s response to insulin.

  • Together, they provide enhanced blood sugar control compared to either drug alone.

• Uses:

  • Type 2 diabetes mellitus – when diet, exercise, and single-drug therapy are insufficient.

  • Helps control both fasting and post-meal blood sugar levels.

• Treatment Goal: To maintain blood glucose within target range, prevent complications of diabetes, and improve overall metabolic control.

• Side Effects:

  • Common: nausea, vomiting, diarrhea, abdominal discomfort, mild hypoglycemia (mainly due to Gliclazide).

  • Less common/serious: severe hypoglycemia, lactic acidosis (rare, mainly due to Metformin), liver or kidney function changes, allergic reactions.

• Precautions:

  • Monitor blood sugar regularly to avoid hypoglycemia.

  • Take with meals to reduce stomach upset and hypoglycemia risk.

  • Caution in patients with kidney, liver, or heart problems.

  • Not recommended during pregnancy or breastfeeding unless prescribed.

  • Avoid excessive alcohol, which may increase the risk of lactic acidosis.

  • Inform the doctor about other medications to prevent interactions.

👉 This combination is effective because it targets blood sugar control through two complementary mechanisms: Gliclazide increases insulin secretion, while Metformin improves insulin sensitivity and reduces liver glucose production.